A specialty pharmaceutical company focused on the development and commercialization of difficult to make products.

About Us

Partnerships

Our aim is to be a partner that you can trust and foster relationships where the whole is greater than the sum of its parts.

Products

We focus on developing difficult generic and 505(b)(2) products. Through our strong domestic and global partnerships, products will include both patented and off-patented brands and generics.

Markets

We target products to the retail, institutional and specialty pharmaceutical markets. Prioritizing patient access is one of our key Company Values.

Our Pipeline

Epilepsy

Oral Solid

Launch: Q2 2022

Hypertension

Injection

Launch: Q3 2023

Acidosis

Injection

Launch: Q4 2022

Epilepsy

Oral Solid

Launch: Q2 2022

Hypertension

Injection

Launch: Q3 2023

Acidosis

Injection

Launch: Q4 2022

Contact Us

We’re happy to share more about the scope of our products, team, markets and answer questions. Reach out and we’ll schedule a time to connect.

We look forward to connecting.